NewsRamp Science, Exploration and Discovery Podcast
Subscribed: 1Played: 1
Subscribe
Description
Explore the wonders of science with the 'NewsRamp Science Podcast.' Each episode offers the latest news and detailed summaries from NewsRamp.com, covering scientific breakthroughs, research advancements, and technological innovations. Stay informed on the discoveries that shape our understanding of the world.
212 Episodes
Reverse
Scientists have found that glioblastoma can erode the skulls of patients, challenging previous assumptions and potentially explaining the low success rates of treatments. Companies like CNS Pharmaceuticals Inc. are working on new treatments for this deadly brain cancer. Meanwhile, the American Heart Association is hosting a data visualization challenge to revolutionize nutrition information using molecular data, offering cash prizes and global participation.
Annovis Bio reports positive results for buntanetap in Alzheimer's patients, Eloro Resources expands mineralization at Iska Iska Project, and GeoVax Labs prepares to present COVID-19 vaccine data at World Vaccine Congress Europe 2025.
Ocumetics Technology Corp. reports positive outcomes for patients receiving the Ocumetics Accommodating Intraocular Lens, while Oncotelic Therapeutics Inc. prepares for clinical trials of Sapu003 to enhance Everolimus bioavailability. Additionally, Ohio State University Wexner Medical Center researchers discover TexPSR stress pathway impacting immunotherapy efficacy, offering hope for improved cancer treatment outcomes.
Dr. Amit Khera, a prominent figure in preventive cardiology and cardiovascular risk assessment, is being honored with the 2025 Chairman’s Award at the American Heart Association’s Scientific Sessions in November. His innovative work includes the development of the Astro-CHARM calculator and utilizing the blood donation system to screen for familial hypercholesterolemia, showcasing his commitment to improving cardiovascular health. Dr. Khera's passion for preventive cardiology is fueled by his dedication to patient care and his extensive contributions to the field have earned him this prestigious recognition.
Soligenix Inc. receives positive safety review for Phase 3 study of HyBryte, Fathom Nickel Inc. achieves full ownership of Gochager Lake Property in Saskatchewan, Nova Minerals focuses on Estelle Project in Alaska, and Lund University researchers uncover insights on leukemia cells evasion. LaFleur Minerals Inc. progresses in gold exploration and processing operations in Quebec, showcasing promising results.
A study from Stanford University revealed that pulsed shortwave therapy (PSWT) offers sustained pain relief for thumb CMC osteoarthritis, while a diet high in fiber and antioxidants can combat the negative effects of junk food. PSWT showed significant pain reduction compared to a sham device, and the approach outlined in 'Counteract the Fat' by DéShond L Barnes provides a less restrictive way to control cholesterol and weight, reducing chronic disease risks.
LaFleur Minerals Inc. has enlisted ERM for a Preliminary Economic Assessment to support the reopening of the Beacon Gold Mill, utilizing material from the Swanson Gold Deposit in Quebec. The company focuses on gold projects in the Abitibi Gold Belt, with the Swanson Gold Project covering vast hectares rich in gold and critical metals. The Beacon Gold Mill, capable of processing over 750 tonnes per day, is fully permitted and poised to enhance development opportunities.
A study of 238 high-oil peanut varieties in China reveals the challenges and potential of these varieties, including trade-offs between oil and protein content, disease resistance levels, and the importance of genetic diversity. The findings provide a foundation for future breeding strategies to enhance yield, quality, and resilience in peanut production, with implications for economic and nutritional benefits in China's leading peanut industry.
ESGold Corp., a pre-production stage company, has secured two rounds of funding to develop historic tailings processing at its Montauban project. The company aims to generate high-margin revenues, minimize dilution, and advance gold/silver discovery efforts, with infrastructure expected to be completed by mid-Q4, 2025.
Lahontan Gold Corp. is advancing its Santa Fe project in Nevada, Soligenix Inc. is developing treatments for antibiotic-resistant bacteria, and Foremost Clean Energy Ltd. is exploring uranium projects to support global clean energy demand. Stay informed on these innovative companies' progress and industry updates.
Quantum Critical Metals Corp. completed a MAG-TDEM airborne survey at the NMX East Property in Northern Quebec, uncovering a magnetic anomaly akin to the Nisk deposit. The survey revealed bedrock conductors at greater depths than before, indicating potential for lithium, nickel, and platinum group elements. CEO Marcy Kiesman is optimistic about the findings and plans to pursue drill targets and permits, with updates for shareholders anticipated in the near future.
Quantum BioPharma Ltd. has brought on Dr. Jack Antel, a respected multiple sclerosis specialist, as a clinical advisor for their MS program. With his vast experience and expertise, Dr. Antel will play a key role in guiding the development of Lucid-21-302 ('Lucid-MS') as the company progresses into Phase 2 studies.
Dr. Judith S. Hochman will be honored with the 2025 Research Achievement Award at the American Heart Association’s Scientific Sessions for her influential research in cardiology, including landmark studies like the SHOCK Trial and the ISCHEMIA Trial, which have significantly enhanced patient care and survival rates globally. Her dedication to advancing women's cardiovascular health and leadership in clinical trials have solidified her reputation as a visionary leader in the field.
Lantern Pharma Inc. prepares for a clinical trial targeting a rare pediatric disease with its investigational therapy LP-184/STAR-001, while City of Hope explores the use of scorpion venom in fighting brain cancer. Additionally, Tonix Pharmaceuticals Holding Corp. advances TNX-2900 for Prader-Willi Syndrome, and Soligenix Inc. expands its European Medical Advisory Board for a Phase 3 trial of HyBryte in cutaneous T-cell lymphoma. Exciting developments are underway in the biopharmaceutical industry to address unmet medical needs in various conditions.
A study in Food Quality and Safety reveals that curdlan, a natural polysaccharide, can significantly improve pineapple jam production by reducing cooking time, enhancing texture, and maintaining taste. This alternative to pectin has the potential to reduce food waste, keep jams affordable, and offer a sustainable solution for the food industry.
VolitionRx Ltd. partners with Hologic Diagenode to promote their Nu.Q® Discover service, targeting drug developers and scientists, while Fathom Nickel Inc. expands its exploration efforts at Gochager Lake post-wildfire exposure, aiming to define a mineralized corridor. CEO statements highlight the growth potential in these respective industries.
Fitzroy Minerals Inc. reports significant progress in extending mineralization zones at Buen Retiro and Caballos copper projects in Chile, while URZ3 Energy Corp. initiates an exploration program for uranium in Wyoming. Megan McLaughlin, M.D., M.P.H., is honored with the 2025 Dr. Nanette K. Wenger Research Goes Red® Award for her impactful research on postpartum care and heart health in women. Tevard Biosciences, Inc. presents promising preclinical data at the 2025 FEBS Special Meeting, showcasing advancements in Duchenne muscular dystrophy and dilated cardiomyopathy treatments.
Trilogy Metals Inc., Nicola Mining Inc., Fairchild Gold Corp., Torr Metals Inc., and LaFleur Minerals are key players in North America's critical minerals industry. From rich copper resources in Alaska to high-grade copper values in Nevada and near-term gold production in Canada, these companies are strategically positioned to meet the growing demand for critical minerals like copper, gold, zinc, lead, and silver. Investors looking to capitalize on the booming market can find opportunities with these innovative mining companies.
A Massachusetts Maritime Academy student co-authors a research article on microbiomes in the Southern Ocean, showcasing the impact of undergraduates in marine science. Lahontan Gold Corp. reports successful drilling results at the Santa Fe Mine project, enhancing its financial position. ESGold Corp. is highlighted for its growth potential in the current gold market outlook. Lahontan Gold Corp. advances in the National Environmental Policy Act review for its Exploration Plan of Operations. Foremost Clean Energy Ltd. progresses with drill programs in Saskatchewan and Manitoba, focusing on uranium and gold-lithium exploration. Additionally, innovative approaches in immunotherapy, including research on zeaxanthin and oncolytic virus therapy, are expected to improve cancer treatment outcomes.
Clene Inc. showcased encouraging outcomes from the REPAIR-MS trial at ECTRIMS 2025 Congress, demonstrating that CNM-Au8 enhanced brain NAD+/NADH ratios in MS patients, impacting energy capacity. The treatment correlated with changes in brain NAD+ and NADH fractions, influencing disability and cognitive function. CNM-Au8 exhibited good tolerability and potential in slowing MS progression by addressing bioenergetic failure, positioning it as a hopeful therapy under investigation by Clene Inc., a biopharmaceutical company specializing in neurodegenerative diseases.
Comments
Download from Google Play
Download from App Store
United States